Botulinum Toxin Enhanced Foker Process for Long Gap Esophageal Atresia

In brief

Novel surgical approach combines botulinum toxin A with the established Foker traction technique to treat long gap esophageal atresia in neonates. BTX's anti-fibrotic and muscle-relaxing properties may accelerate esophageal growth, potentially reducing operative stages and improving outcomes in this challenging congenital condition.

• Foker process uses progressive tension to induce esophageal growth in long gap esophageal atresia (LGEA).
• Botulinum Toxin A (BTX) has anti-fibrotic and muscle-relaxing properties relevant to esophageal tissue manipulation.
• BTX may enhance traction-induced esophageal growth when combined with the Foker technique.
• Novel approach targets both mechanical tension and tissue properties to improve LGEA surgical outcomes.

Written by the GCMD Library team from the article.